Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future

Pharmacoepidemiological studies may lack the power to detect very rare adverse events like drug-induced Torsade de Pointes, highlighting the need for proactive surveillance such as a national registry for drug-induced QT prolongation.